Tag | Content |
---|
EnhancerAtlas ID | HS182-10637 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr19:907000-907970 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
KLF16 | MA0741.1 | chr19:907449-907460 | GGGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr19:907450-907460 | GGGGCGGGGC | - | 6.02 | Nr2f6(var.2) | MA0728.1 | chr19:907033-907048 | TGAACTCCTGACCTT | - | 6.04 | PLAG1 | MA0163.1 | chr19:907354-907368 | CCCCCTGAGGCCCC | - | 6.02 | SP4 | MA0685.1 | chr19:907446-907463 | AGAGGGGGCGGGGCTCG | - | 6.24 | SREBF2 | MA0596.1 | chr19:907500-907510 | ATCACCCCAT | - | 6.02 | Zfx | MA0146.2 | chr19:907954-907968 | GAGGCCGAGGCGGG | - | 6.01 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_10779 | chr19:905539-911000 | CD19_Primary |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH19I000906 | chr19 | 906185 | 910931 |
|
Enhancer Sequence | AGACGGGGTT TCACCATGTT GGCAGGCTGG TCTTGAACTC CTGACCTTAA GTGATCCGCC 60 TGCCTCAGCC TCCCAAAGTG CTGGGATTAC AGGCATGAGC TACCACGCCC GGCCCTCATT 120 ATACAGATTT GTAAACCAAG GCACAAAGTC ACCGCCCAAG CTCCCATTGC TGCAAAGAGG 180 GCAGCTGGAG AAGGAGGTGG TGGACCATGC CCTCAGCACA GAGCACAGCA GCCGACGGGT 240 ACTCAGTGGG AATACAGGGT CATGTTAAGC CAGCGTCTCT GAAGCTGGAT CAGCCTGAAG 300 CTGCCTCCCT GAGGCCGGAG CACTCTGTCC CATGCCCCAG ATTCACCCAC AGCCCCCCCT 360 GAGGCCCCGG GGCCTACTTC TCCACCCCAG CAGCTGGACA GGGCCGATAA CAGAAGTGAC 420 ATCCGAGGGG AGCCCTCGGG GAAGTCAGAG GGGGCGGGGC TCGGTGACAC AGCTCAAGCC 480 CTCCCAGCAA GGGGCCTGGT ATCACCCCAT ATTACAGATG AAGGATCTGA GGCTTGGAGA 540 GGTGGGGCTG TCCCCCGTCA CCACCCAGAC AATGCAAGGA GCTGGATGTG AACCTGGGTC 600 TGACCCAGAA CCCCAGAGCT ACCCTGCTTC CCTCACCACC CCTCATACCA AAGCCCCACA 660 GGCCTCTCCT CCAGGCCCAC AAGGACCTGC CTGGTCCTTC CCCTGCTCCA GCACAGCCCA 720 TGGCTCCCCA GCATCCCAGG GCCAGGCCTG GCTCCCCCTT GGCCTAGCAC TGCAACACGA 780 GGGCTTTCGC CTGTTTTGTT TGGTATCTGA GGGCTCGCCA CCCTCCCCTG GGTCTCTAGT 840 GCTGAGCTGA GCACTGGAAA TCGAGTCCCA CCATCAGATG GAGCTGGCTG ACTTCAACCA 900 GTTTCCAGCA GGAAATTAAG AAACATCTTC AAGCTTGTCA TCCCAGCACT TTGGGAGGCC 960 GAGGCGGGCG 970
|